Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Data Monetization

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1791614

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1791614

Data Monetization Solutions for Life Science Companies

PUBLISHED:
PAGES: 158 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Data Monetization Solutions for Life Science Companies Market to Reach US$1.1 Billion by 2030

The global market for Data Monetization Solutions for Life Science Companies estimated at US$416.9 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 17.5% over the analysis period 2024-2030. Indirect Data Monetization, one of the segments analyzed in the report, is expected to record a 20.1% CAGR and reach US$744.8 Million by the end of the analysis period. Growth in the Direct Data Monetization segment is estimated at 13.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$109.6 Million While China is Forecast to Grow at 16.4% CAGR

The Data Monetization Solutions for Life Science Companies market in the U.S. is estimated at US$109.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$167.7 Million by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.5% and 14.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global Data Monetization Solutions for Life Science Companies - Key Trends & Growth Drivers Summarized

Why Is Data Monetization Transforming the Life Sciences Industry?

Life science companies, including pharmaceutical firms, biotechnology enterprises, and clinical research organizations, generate vast amounts of data through clinical trials, genomics, drug discovery, and patient monitoring. Data monetization is enabling these organizations to unlock new revenue streams, optimize research and development (R&D), and improve patient outcomes through AI-driven insights. By leveraging anonymized and structured datasets, life science firms can accelerate drug development, enhance precision medicine, and drive innovation in personalized healthcare solutions.

The shift toward digital health, real-world evidence (RWE) utilization, and AI-powered diagnostics has further intensified the need for data monetization strategies. Through strategic collaborations with healthcare providers, payers, and regulatory agencies, life science companies are leveraging data-driven insights to improve decision-making, identify market trends, and streamline clinical research. The growing adoption of cloud-based analytics platforms and blockchain-enabled data marketplaces is also facilitating secure and compliant data transactions, ensuring ethical monetization of life science data.

What Are the Latest Innovations in Life Sciences Data Monetization?

Advancements in AI, machine learning (ML), and data interoperability have significantly enhanced the capabilities of data monetization in life sciences. One of the most notable innovations is federated learning, which allows AI models to analyze decentralized datasets across multiple institutions without exposing sensitive patient information. This approach is improving collaboration in drug discovery, biomarker identification, and personalized treatment planning while maintaining compliance with data privacy regulations.

Another breakthrough is the development of tokenized health data exchanges, where anonymized datasets can be securely traded for research purposes. Blockchain technology is ensuring transparency, data integrity, and controlled access, enabling life science companies to share genomic, proteomic, and clinical trial data with authorized stakeholders. Additionally, AI-powered data harmonization tools are optimizing the integration of heterogeneous datasets, allowing companies to derive actionable insights from disparate sources. The use of synthetic data-AI-generated datasets that mimic real patient information without compromising privacy-is also gaining traction as an ethical and regulatory-compliant alternative for data monetization.

How Are Market Trends and Regulatory Policies Influencing Life Science Data Monetization?

The increasing emphasis on evidence-based medicine, real-world data (RWD) utilization, and AI-driven research has propelled the adoption of data monetization strategies in the life sciences sector. Life science companies are partnering with healthcare organizations, academic institutions, and AI firms to leverage large-scale data analytics for improved drug efficacy and patient stratification.

Regulatory frameworks such as HIPAA, GDPR, and the FDA’s Real-World Evidence Program have significantly shaped data monetization policies. Companies must adhere to strict guidelines on data anonymization, patient consent, and ethical usage to ensure compliance while commercializing health data assets. Additionally, the rise of data governance initiatives and interoperability standards such as FHIR (Fast Healthcare Interoperability Resources) has facilitated seamless data sharing and monetization across different stakeholders.

What Is Driving the Growth of the Data Monetization Solutions for Life Science Companies Market?

The growth in the data monetization market for life science companies is driven by the increasing use of AI-driven analytics, advancements in genomics and drug discovery, and the growing demand for real-world data insights. The rise of personalized medicine and precision healthcare has further fueled the need for structured, high-quality datasets that can inform targeted therapies and treatment optimization.

End-use expansion is another key factor, with data monetization being leveraged in clinical research, pharmacovigilance, and population health management. The integration of AI-powered data marketplaces, cloud-based analytics, and blockchain-secured data transactions is accelerating adoption. Additionally, strategic partnerships between pharmaceutical firms, biotech startups, and data security companies are fostering innovation, ensuring that life science data monetization solutions align with industry needs while maintaining compliance and ethical integrity.

SCOPE OF STUDY:

The report analyzes the Data Monetization Solutions for Life Science Companies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Indirect Data Monetization, Direct Data Monetization); Deployment (Cloud Deployment, On-Premises Deployment); Facility Size (Large Facilities, Small and Medium Facilities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • Accenture plc
  • Cerner Corporation
  • Cisco Systems, Inc.
  • GE Healthcare
  • Google LLC
  • Infosys Limited
  • McKesson Corporation
  • Medidata Solutions
  • Microsoft Corporation
  • OpenText Corporation
  • Oracle Corporation
  • Particle Health, Inc.
  • Salesforce, Inc.
  • SAP SE
  • SAS Institute Inc.
  • Scientist.com
  • Siemens AG
  • Snowflake Inc.
  • TIBCO Software Inc.
  • Veeva Systems Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP30367

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Data Monetization Solutions for Life Science Companies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Explosion of Omics, Clinical, and Real-World Data Throws the Spotlight on Data Monetization as a Strategic Growth Lever in Life Sciences
    • Rising R&D Costs and Lengthening Drug Development Timelines Strengthen the Business Case for Commercializing Proprietary Data Assets
    • Increased Adoption of Real-World Evidence (RWE) and Real-World Data (RWD) for Regulatory Submissions Expands Monetization Opportunities
    • Growing Demand for Patient-Centric and Precision Medicine Models Drives the Need for High-Granularity, Monetizable Datasets
    • Integration of Clinical Trial, Genomic, and Longitudinal Health Data Enables Development of High-Value, Multi-Dimensional Data Products
    • Digital Transformation Across Pharma and Biotech Spurs Investment in Data Lakes, Marketplaces, and Data-as-a-Service (DaaS) Platforms
    • Emergence of AI-Driven Drug Discovery Models Creates Demand for Proprietary, High-Quality Labeled Datasets
    • Post-Approval Market Surveillance and Pharmacovigilance Programs Leverage Monetized Data Streams from Internal and Partner Systems
    • Expansion of Companion Diagnostics and Biomarker Discovery Initiatives Fuels Commercialization of Clinical and Lab Data Assets
    • Integration of EHR, Claims, Imaging, and Wearable Data Sources Increases Scope for Licensing and Data Sharing Agreements
    • Shift Toward Outcome-Based and Risk-Sharing Agreements Drives Life Sciences Companies to Monetize Insights-Driven Data Products
    • Adoption of Federated Learning and Privacy-Preserving Analytics Enables Data Sharing Without Compromising IP or Patient Privacy
    • Rising Regulatory Pressure for Transparent and Explainable AI Strengthens Demand for Traceable, Governed Data Sources
    • Growth of Digital Therapeutics and Connected Health Devices Adds New Monetizable Data Streams from Patient Usage Patterns
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Data Monetization Solutions for Life Science Companies Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Indirect Data Monetization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Indirect Data Monetization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Direct Data Monetization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Direct Data Monetization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cloud Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Cloud Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for On-Premises Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for On-Premises Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Large Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Large Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Small & Medium Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Small & Medium Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • JAPAN
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • CHINA
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • EUROPE
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • FRANCE
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • GERMANY
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Germany 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Italy 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • UNITED KINGDOM
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: UK 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 72: Rest of Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Data Monetization Solutions for Life Science Companies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 78: Asia-Pacific Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Asia-Pacific 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 84: Rest of World Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Type - Indirect Data Monetization and Direct Data Monetization - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of World 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Type - Percentage Breakdown of Value Sales for Indirect Data Monetization and Direct Data Monetization for the Years 2025 & 2030
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Deployment - Cloud Deployment and On-Premises Deployment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Deployment - Percentage Breakdown of Value Sales for Cloud Deployment and On-Premises Deployment for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Data Monetization Solutions for Life Science Companies by Facility Size - Large Facilities and Small & Medium Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Data Monetization Solutions for Life Science Companies by Facility Size - Percentage Breakdown of Value Sales for Large Facilities and Small & Medium Facilities for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!